Navigation Links
AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
Date:5/20/2013

D, accounting for nearly 44 percent of new cases in the US.vii The number of people with diabetes continues to rise and as a result, the number of people with kidney failure caused by diabetes is growing.iii  Some experts predict that diabetes might soon account for half the cases of kidney failure.vii

About Atrasentan

Atrasentan is an investigational compound that belongs to a class of drugs known as selective endothelin-A receptor antagonists, which block the effect of endothelin-l (ET-l), a peptide that constricts blood vessels in the kidney to negatively impact kidney functions.  Atrasentan is a highly selective endothelin-A receptor antagonist that was discovered and is being developed internally at AbbVie.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

i Clinical Study Protocol M11-352. AbbVie. Date Accessed: April 1, 2013.

ii European Renal Association - European Dialysis and Transplantation Association (ERA-EDTA). Oral Presentation 034932, "The Selective Type A Endothelin Antagonist Atrasentan Reduces Residual Albuminuria in Patients with Type 2 Diabetes and Nephropathy." <
'/>"/>

SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AbbVie Named to S&P 500 Dividend Aristocrat Index
2. AbbVie Issues Inaugural Full-Year Outlook for 2013
3. AbbVie to Present at Barclays Global Health Care Conference
4. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
5. AbbVie to Host First-Quarter Earnings Conference Call
6. AbbVie Reports First-Quarter 2013 Financial Results
7. AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
8. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
9. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
10. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
11. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014  ProteinSimple announced today that it has launched ... assay allows users to detect all proteins separated in ... users can analyze proteins without the need for an ... protein analysis as we know it today. First, the Simple ... no messy gels, no transfer tanks, no blots, no ...
(Date:7/28/2014)... Germany and LONDON ... , Collaboration aims to create and commercialize ... guide the use of IRESSA  for non-small cell lung ... on QIAGEN,s FDA-approved  therascreen   EGFR test and is planned ... automated instruments  Project enabled by AstraZeneca master ...
(Date:7/28/2014)... 28, 2014 OmPrompt today ... to help it meet the global demand for ... and logistics. Albion joins Shackleton Ventures. ... Over the past 18 months OmPrompt has underpinned ... management team and its operations. The new funding ...
Breaking Medicine Technology:ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6OmPrompt Funded for Customer Automation Management Market Expansion 2
... GREEN BAY, Wis., Jan. 10, 2012  With increasing demands ... longer hours or shuttling the children to and from ... of a challenge. To make life simpler for shoppers ... its mobile pharmacy app, allowing users to quickly and ...
... Oramed Pharmaceuticals Inc. (OTCBB:ORMP) ( http://www.oramed.com ... today that it has filed a provisional patent application ... a combination therapy of its lead compound, ORMD-0801 in ... no such approved combination product available on the market ...
Cached Medicine Technology:Shopko Launches Mobile Pharmacy App to Maximize Customer Convenience 2Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes 2Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes 3
(Date:7/28/2014)... NY (PRWEB) July 28, 2014 Glutamine ... body and it’s considered to be conditionally essential during ... and is an advanced recovery & Immune System Support. ... the glutamine your body produces, supplementing with additional glutamine ... of waste products in the body, digestion and immune ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, ... who are at risk of contracting meningitis because of ... according to updated recommendations from the largest pediatrician group ... for the potentially deadly infection should continue for adolescents ... In its first statement on meningococcal vaccines since ...
(Date:7/28/2014)... runners are far more likely to die of heat ... new study. The researchers pointed out that ... actually 10 times more likely to develop severe and ... of a young and apparently healthy person due to ... gets a lot more media attention. "This research ...
(Date:7/28/2014)... 28, 2014 SIMpalm helped its ... App is available on iTunes for download . Experience ... Audio Chef allows you to listen and cook along with ... way: simply get out the ingredients and equipment, press play, ... or prepare ingredients ahead of time, just relax and cook ...
(Date:7/28/2014)... NY (PRWEB) July 28, 2014 The ... organization that has donated more than 200,000 books to ... 2001, announces the launch of Brooke’s Cooks, a new ... while encouraging healthy living among at-risk children and their ... will include a series of nutrition information workshops, cooking ...
Breaking Medicine News(10 mins):Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 4
... the Quality of Life of Injured Veterans , ... study by Kessler Foundation Research Center published in ... Brain Injury Association, uncovered the possible cause of cognitive ... Cognitive fatigue has been shown to be one of ...
... Merz Scales(TM) are the most comprehensive rating system to be ... 34 years , , LAS VEGAS, June 11 ... measure the skin,s aging process, were presented at THE Aesthetic ... multidisciplinary experts to "establish a universal language of aging," The ...
... Final Year of Developing Criteria for Behavioral Health EHR ... The Certification Commission for Healthcare Information Technology (CCHIT(R)) ... M.D., to its Behavioral Health Work Group for 2009-2010. ... composed of a diverse group of healthcare stakeholders and ...
... process to store most relevant information, study shows , THURSDAY, ... memory, but the sleeping brain seems to store only the ... a group of 44 college students aged 18 to 22, ... follows a period of learning, sleep can preserve the most ...
... IPC The Hospitalist Company, Inc. (Nasdaq: ... company, announced today that it has acquired the hospitalist ... Based in Morristown, New Jersey, the acquisition establishes ... Company,s national presence to 19 states. IPC expects to ...
... and Configuration Scanning Service Helps Healthcare Organizations Improve ... Effective Solution , , SAN FRANCISCO, June ... compliance auditing solutions, and Health Information Trust Alliance ... as the provider of vulnerability and configuration assessments ...
Cached Medicine News:Health News:Kessler Foundation Research Center Study Provides Insight into One of the Most Challenging Symptoms Following a Traumatic Brain Injury 2Health News:Kessler Foundation Research Center Study Provides Insight into One of the Most Challenging Symptoms Following a Traumatic Brain Injury 3Health News:First-Ever Standardized Scales to Measure the Skin's Aging Process Are Presented at THE Aesthetic Show 2Health News:Netsmart's Haines Reappointed to CCHIT Behavioral Health Work Group 2Health News:IPC The Hospitalist Company Expands Into New Jersey 2Health News:nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 2Health News:nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 3Health News:nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 4
IRMA kit for detection of the cardiac marker Myoglobin...
... The assay is an immunometric ... measurement of Prolactin in human ... the sample is bound by ... different epitopes. One antibody is ...
... Immunosorbent Assay (ELISA) serves the quantitative,determination of ... serum and,urine. In a 1 hour incubation ... bound to an,available excess of polyclonal rabbit ... surface of the microtitre plates. After a ...
... method for the semi-quantitative determination of ... human serum. The results of the ... an aid in the diagnosis of ... with elevated anti-neutrophil cytoplasmic antibodies (P-ANCA) ...
Medicine Products: